How AI-Based Bioreactors Can Improve Enzyme Production episode artwork

EPISODE · Sep 1, 2026 · 28 MIN

How AI-Based Bioreactors Can Improve Enzyme Production

from Off Script: A Pharma Manufacturing Podcast · host Pharma Manufacturing

Researchers have developed a new sensor-enabled bioreactor that uses machine learning technology for improved enzyme production. This advanced technology—created by researchers at Iowa State University and Novonesis, with funding by BioMADE—pairs continuous monitoring with AI-guided control to give manufacturers a faster, more precise way to manage enzyme production. In this episode of Off Script, we connected with Mike Hess, senior regional technology manager at Novonesis, and David Nathan, program director at BioMADE, to discuss the development of the new bioreactor and how real-time monitoring and AI-based control help manufacturers automate previously manual processes, improve batch consistency, and ultimately accelerate the path to market. The conversation also explored how the project led to the development of low-cost bioreactors that researchers are now working to turn into hands-on bioprocessing educational kits for students.

Episode metadata supplied by the publisher feed · Published Sep 1, 2026

Embed this episode

Ready to play

How AI-Based Bioreactors Can Improve Enzyme Production

0:00 28:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Off Script: A Pharma Manufacturing Podcast?

This episode is 28 minutes long.

When was this Off Script: A Pharma Manufacturing Podcast episode published?

This episode was published on September 1, 2026.

Can I download this Off Script: A Pharma Manufacturing Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!